在使用生物治疗的牛皮患者中潜伏的结核病感染
Fernanda Luiza Staub1, André Kulzer Santos2, Raimunda Sinthia Lima de Braga2
1Postgraduate Program in Pulmonary Sciences, Federal University of Rio Grande do Sul, Porto Alegre; Dermatology Department, Porto Alegre Clinical Hospital.
概括
潜伏性结核感染 (LTBI) 在开始生物治疗的牛皮患者中很常见,24.6%的患者在治疗前被诊断出来. 建议每年对在结核病流行地区接受生物治疗的患者进行LTBI查.
科学领域:
- 皮肤病学 皮肤病学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 牛皮患者患有潜在结核病感染 (LTBI) 和活性结核病 (TB) 的风险更高.
- 生物疗法越来越多地用于牛皮,需要评估结核病风险.
研究的目的:
- 确定牛皮患者在生物治疗前和期间的LTBI的患病率.
- 用生物药物评估牛皮患者活跃结核病的发病率.
主要方法:
- 一项具有追溯数据收集的横截面研究.
- 审查了126名接受生物治疗的成年牛皮患者的电子病历.
- 收集了有关牛皮,生物类型和结核素皮肤测试 (TST) 结果的数据.
主要成果:
- 在开始使用生物药物之前,24.6%的患者患有LTBI.
- 另外16.8%的人在生物治疗期间被诊断为LTBI.
- 在生物治疗期间没有观察到活跃结核病病例.
结论:
- 在结核病流行地区,显著比例的牛皮患者患有LTBI.
- 常规的年度LTBI查对于在高发病率环境中服用生物药物的牛皮患者至关重要.
相关概念视频
Pulmonary Tuberculosis IV
207
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Pulmonary Tuberculosis III
452
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
452
Pulmonary Tuberculosis I
332
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
332
Pulmonary Tuberculosis II
381
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
381
Pulmonary Tuberculosis V
246
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
246
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
239
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
239


